Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.90 Insider Own2.63% Shs Outstand15.97M Perf Week-3.70%
Market Cap16.61M Forward P/E- EPS next Y-0.52 Insider Trans0.00% Shs Float15.55M Perf Month-3.70%
Income-10.26M PEG- EPS next Q-0.17 Inst Own9.70% Short Float1.89% Perf Quarter-12.61%
Sales0.00M P/S- EPS this Y37.14% Inst Trans- Short Ratio0.11 Perf Half Y-23.53%
Book/sh0.43 P/B2.43 EPS next Y21.21% ROA-151.13% Short Interest0.29M Perf Year-67.40%
Cash/sh0.40 P/C2.60 EPS next 5Y- ROE-186.26% 52W Range0.86 - 3.66 Perf YTD-36.59%
Dividend Est.- P/FCF- EPS past 5Y15.28% ROI-165.88% 52W High-71.58% Beta1.68
Dividend TTM- Quick Ratio5.92 Sales past 5Y0.00% Gross Margin- 52W Low20.92% ATR (14)0.10
Dividend Ex-Date- Current Ratio5.92 EPS Y/Y TTM47.96% Oper. Margin0.00% RSI (14)48.69 Volatility4.13% 11.39%
Employees22 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price7.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q52.61% Payout- Rel Volume0.03 Prev Close1.04
Sales Surprise- EPS Surprise0.00% Sales Q/Q- EarningsMay 14 Avg Volume2.65M Price1.04
SMA20-3.53% SMA504.09% SMA200-17.54% Trades Volume83,646 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jan-13-20Reiterated H.C. Wainwright Buy $12 → $26
Dec-24-19Reiterated H.C. Wainwright Buy $10 → $12
Jan-31-18Initiated Ladenburg Thalmann Buy $1.75
Jun-21-24 06:53AM
Jun-20-24 08:25AM
Jun-17-24 08:30AM
Jun-04-24 04:20PM
12:11PM Loading…
Jun-03-24 12:11PM
May-15-24 11:53PM
Apr-29-24 08:30AM
Apr-15-24 08:30AM
Mar-27-24 10:53PM
Feb-07-24 10:08AM
Feb-05-24 07:30AM
Jan-30-24 07:20AM
Jan-18-24 07:20AM
10:12AM Loading…
Jan-03-24 10:12AM
Dec-29-23 08:00AM
Dec-28-23 07:30AM
Dec-14-23 08:15AM
Dec-10-23 02:31PM
Dec-07-23 08:00AM
Nov-21-23 09:12AM
Nov-13-23 08:30AM
Nov-08-23 09:10AM
Oct-31-23 08:25AM
Oct-24-23 08:19AM
Oct-19-23 08:20AM
Oct-17-23 09:28AM
Sep-27-23 08:30AM
Sep-08-23 10:02AM
08:30AM Loading…
Aug-15-23 08:30AM
Aug-10-23 08:30AM
Jul-25-23 09:23AM
Jul-11-23 08:30AM
Jun-29-23 08:30AM
Jun-28-23 02:05PM
Jun-27-23 08:00AM
Jun-22-23 08:36AM
Jun-16-23 08:30AM
Jun-06-23 12:33PM
Jun-02-23 12:36PM
May-31-23 08:30AM
May-25-23 08:40AM
May-24-23 01:05PM
May-23-23 03:24PM
May-22-23 03:18PM
May-18-23 09:15AM
May-08-23 08:30AM
May-05-23 09:00AM
May-03-23 09:00AM
Mar-23-23 09:00AM
Mar-16-23 09:00AM
Mar-13-23 09:00AM
Mar-09-23 09:00AM
Mar-02-23 09:00AM
Feb-28-23 09:00AM
Feb-27-23 09:00AM
Feb-23-23 08:00AM
Jan-31-23 07:30AM
Jan-06-23 07:00AM
Dec-21-22 09:55AM
Dec-14-22 08:30AM
Dec-08-22 07:00AM
Nov-21-22 03:04PM
Nov-18-22 09:00AM
Nov-15-22 07:00AM
Nov-08-22 06:42AM
Nov-03-22 07:00AM
Oct-31-22 07:00AM
Oct-25-22 04:01PM
Oct-21-22 08:00AM
Oct-18-22 08:45AM
Oct-13-22 09:15AM
Oct-11-22 09:00AM
Oct-10-22 07:00AM
Oct-07-22 08:36AM
Oct-04-22 08:30AM
Sep-19-22 07:00AM
Sep-15-22 09:00AM
Sep-13-22 07:00AM
Sep-12-22 08:00AM
Sep-08-22 07:00AM
Sep-06-22 09:00AM
Sep-02-22 07:00AM
Aug-18-22 07:00AM
May-25-22 10:34AM
Apr-06-22 04:05PM
Mar-31-22 07:00AM
Jan-24-22 02:16PM
Dec-28-21 09:42AM
Dec-27-21 12:11PM
Dec-23-21 11:30AM
Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Braintree, MA.